Basic information Uses Safety Supplier Related

2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBOXYLIC ACID

Basic information Uses Safety Supplier Related

2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBOXYLIC ACID Basic information

Product Name:
2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBOXYLIC ACID
Synonyms:
  • 3,4-DIHYDRO-1H-ISOQUINOLINE-2,7-DICARBOXYLIC ACID 2-TERT-BUTYL ESTER
  • 2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBOXYLIC ACID
  • N-BOC-7-HYDROXYCARBONYL-1,2,3,4-TETRAHYDROISOQUINOLINE
  • 2-Boc-1,2,3,4-Tetrahydroisoquinoline-7-Carboxylic Acid
  • 7-Isoquinolinecarboxylicacid-N-tertbutylester
  • 2-Boc-1,2,3,4-tetrahydro-...
  • N-Boc-1,2,3,4-tetrahydroisoquinoline-7-carboxylic acid
  • 2-[(2-methylpropan-2-yl)oxycarbonyl]-3,4-dihydro-1H-isoquinoline-7-carboxylic acid
CAS:
149353-95-7
MF:
C15H19NO4
MW:
277.32
Product Categories:
  • pharmacetical
Mol File:
149353-95-7.mol
More
Less

2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBOXYLIC ACID Chemical Properties

Melting point:
151-153 °C
Boiling point:
429.3±45.0 °C(Predicted)
Density 
1?+-.0.06 g/cm3(Predicted)
storage temp. 
2-8°C
pka
4.37±0.20(Predicted)
Appearance
Light brown to yellow Solid
More
Less

2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBOXYLIC ACID Usage And Synthesis

Uses

2-BOC-7-carboxy-1,2,3,4-tetrahydroisoquinoline is a quinoline derivative used in pharmaceutical synthesis and experimental research.

Synthesis

960305-54-8

149353-95-7

2-tert-butyl 7-methyl 3,4-dihydroisoquinoline-2,7(1H)-dicarboxylate (450 mg, 1.545 mmol) was used as a raw material and dissolved in tetrahydrofuran (THF, 2 mL) and methanol (MeOH, 1 mL). Lithium hydroxide (LiOH, 111 mg, 4.63 mmol) and water (H2O, 1 mL) were added. The reaction mixture was heated to 60 °C and stirred at this temperature for 3 hours. Upon completion of the reaction, the solvent was evaporated until the remaining predominantly aqueous layer. The aqueous layer was cooled in an ice bath and adjusted to slightly acidic by slowly adding 5 M hydrochloric acid (HCl) dropwise. Extraction was performed with ethyl acetate (EtOAc, 10 mL) and water (H2O, 10 mL). The aqueous layer was again extracted with ethyl acetate (10 mL). The organic layers were combined, dried and concentrated to give a colorless oil, which was solidified overnight under reduced pressure. The resulting solid precipitate was ground in methyl tert-butyl ether (MTBE), filtered and dried to afford 2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-7-carboxylic acid (260 mg, 58.3% yield).LC/MS m/z = 278.2 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ ppm 1.43 (s , 9H), 2.83 (t, J = 5.87 Hz, 2H), 3.56 (t, J = 5.94 Hz, 2H), 4.55 (s, 2H), 7.28 (d, J = 7.96 Hz, 1H), 7.70-7.75 (m, 2H), 12.84 (br s, 1H).

References

[1] Patent: WO2013/70657, 2013, A1. Location in patent: Page/Page column 153; 175
[2] Patent: US2010/234340, 2010, A1. Location in patent: Page/Page column 63

2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBOXYLIC ACIDSupplier

ITIC MEDCHEM(SUZHOU) CO.,LTD.
Tel
0512-68323967 18015559028
Email
sales@iticmedchem.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
18270980682
Email
mlcheng@sunwaypharm.cn
Shanghai Litong Chemical Technology Co.,Ltd.
Tel
13598610367 0373-7129549
Email
2468833170@qq.com
Nanjing Norris-Pharm Technology Co., Ltd
Tel
18652989687
Email
sales@norris-pharm.com